US4614513A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and apparatus for treatment to remove immunoreactive substances from blood
Assignee: Fred Hutchinson Cancer Center
•
Filing: 1984-08-13
•
Granted: 1986-09-30
•
Expires: 2004-08-13
Abstract
Abstract A method and apparatus are disclosed for treating a patient by removing immunoreactive substances from the patient's blood using microbial ligands such as Staphylococcus Protein A. The method of the present invention comprises removing blood from the patient, separating the removed blood into plasma and cellular components, passing the plasma component through an immunoadsorbent material to produce a treated plasma component, and returning the treated plasma component and the cellular component to the patient. The immunoadsorbent material comprises a microbial ligand such as Staphylococcus Protein A, or components thereof, covalently bonded to an inert and nondegradable support. The removing, separating, passing and returning steps are performed substantially continuously and simultaneously with one another. The immunoadsorbent material may comprise one to three milligrams of the microbial ligand for each gram of support, and about 20-40 ml of the plasma component may be passed through the immunoadsorbent material per minute. In one preferred embodiment, the immunoadsorbent material comprises Staphylococcus Protein A, or components thereof, that have been covalently bonded to a silica support by first coating the silica support with an alkylamine and then coupling Staphylococcus Protein A to the alkylamine by means of a carbodiimide.
Inventors
- 👤 William I. Bensinger
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 16:37
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3679; A61M1/34; A61M1/3472; A61M1/3486; Y; Y10; Y10S; Y10S128/00; Y10S128/03
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
117 words
A method for treating a patient by removing immunoreactive substances from the patient's blood, comprising: removing blood from the patient; separating the removed blood into a plasma component and a cellular component; passing the plasma component through an immunoadsorbent material comprising a microbial ligand covalently bonded to an inert support to thereby produce a treated plasma component, the immunoadsorbent material comprising from one to three milligrams of the microbial ligand for each gram of the inert support, the microbial ligand comprising at least components of Staphylococcus Protein A; and returning the cellular component and the treated plasma component to the patient; the removing, separating, passing and returning steps being performed substantially continuously and simultaneously with one another.
Claim 2
Independent Claim
117 words
A method for treating a patient by removing immunoreactive substances from the patient's blood, comprising: removing blood from the patient; separating the removed blood into a plasma component and a cellular component; passing the plasma component through an immunoadsorbent material comprising a microbial ligand covalently bonded to an inert support to thereby produce a treated plasma component, the immunoadsorbent material comprising from one to three milligrams of the microbial ligand for each gram of the inert support, the microbial ligand comprising at least components of Staphylococcus Protein A; and returning the cellular component and the treated plasma component to the patient; the removing, separating, passing and returning steps being performed substantially continuously and simultaneously with one another.
Claim 3
Dependent Claim
24 words
The method of claim 1, wherein the immunoadsorbent material comprises about two milligrams of the microbial ligand for each gram of the inert support.
Claim 4
Dependent Claim
16 words
The method of claim 1, wherein the mass of the immunoadsorbent material is about 100 grams.
Claim 5
Independent Claim
32 words
A method for treating a patient by removing immunoreactive substances from the patient's blood, comprising: removing blood from the patient; separating the removed blood into a plasma component and a cellular component;
Claim 6
Independent Claim
32 words
A method for treating a patient by removing immunoreactive substances from the patient's blood, comprising: removing blood from the patient; separating the removed blood into a plasma component and a cellular component;
Claim 7
Dependent Claim
91 words
passing the plasma component through an immunoadsorbent material comprising a microbial ligand that has been covalently bonded to a silica support by first coating the silica support with an alkylamine and then coupling the microbial ligand to the alkylamine by means of a carbodiimide to thereby produce a treated plasma component, the microbial ligand comprising at least components of Staphylococcus Protein A; returning the cellular component and the treated plasma component to the patient; and the removing, separating, passing and returning steps being performed substantially continuously and simultaneously with one another.
Claim 8
Dependent Claim
91 words
passing the plasma component through an immunoadsorbent material comprising a microbial ligand that has been covalently bonded to a silica support by first coating the silica support with an alkylamine and then coupling the microbial ligand to the alkylamine by means of a carbodiimide to thereby produce a treated plasma component, the microbial ligand comprising at least components of Staphylococcus Protein A; returning the cellular component and the treated plasma component to the patient; and the removing, separating, passing and returning steps being performed substantially continuously and simultaneously with one another.
Claim 9
Independent Claim
115 words
An apparatus for treating a patient by removing immunoreactive substances from the patient's blood, comprising: means for removing a continuous flow of blood from the patient; means for continuously separating the removed blood into a plasma component and a cellular component; means for continuously passing the plasma component through an immunoadsorbent material comprising a microbial ligand covalently bonded to an inert support to thereby produce a treated plasma component, the immunoadsorbent material comprising from one to three milligrams of the microbial ligand for each gram of the inert support, the microbial ligand comprising at least components of Staphylococcus Protein A; and means for returning the cellular component and the treated plasma component to the patient.
Claim 10
Independent Claim
115 words
An apparatus for treating a patient by removing immunoreactive substances from the patient's blood, comprising: means for removing a continuous flow of blood from the patient; means for continuously separating the removed blood into a plasma component and a cellular component; means for continuously passing the plasma component through an immunoadsorbent material comprising a microbial ligand covalently bonded to an inert support to thereby produce a treated plasma component, the immunoadsorbent material comprising from one to three milligrams of the microbial ligand for each gram of the inert support, the microbial ligand comprising at least components of Staphylococcus Protein A; and means for returning the cellular component and the treated plasma component to the patient.
Claim 11
Dependent Claim
24 words
The apparatus of claim 5, wherein the immunoadsorbent material comprises about two milligrams of the microbial ligand for each gram of the inert support.
Claim 12
Dependent Claim
16 words
The apparatus of claim 5, wherein the mass of the immunoadsorbent material is about 100 grams.
Claim 13
Independent Claim
121 words
An apparatus for treating a patient by removing immunoreactive substances from the patient's blood, comprising: means for removing a continuous flow of blood from the patient; means for continuously separating the removed blood into a plasma component and a cellular component; means for continuously passing the plasma component through an immunoadsorbent material comprising a microbial ligand that has been covalently bonded to a silica support by first coating the silica support with an alkylamine and then coupling the microbial ligand to the alkylamine by means of a carbodiimide, to thereby produce a treated plasma component, the microbial ligand comprising at least components of Staphylococcus Protein A; and means for returning the cellular component and the treated plasma component to the patient.
Claim 14
Independent Claim
121 words
An apparatus for treating a patient by removing immunoreactive substances from the patient's blood, comprising: means for removing a continuous flow of blood from the patient; means for continuously separating the removed blood into a plasma component and a cellular component; means for continuously passing the plasma component through an immunoadsorbent material comprising a microbial ligand that has been covalently bonded to a silica support by first coating the silica support with an alkylamine and then coupling the microbial ligand to the alkylamine by means of a carbodiimide, to thereby produce a treated plasma component, the microbial ligand comprising at least components of Staphylococcus Protein A; and means for returning the cellular component and the treated plasma component to the patient.
References Cited (Backward Citations)
US3995018A
Cited
US3995018B1
Cited
US3995018B2
Cited
US4215688A
Cited
US4464165A
Cited
US4381004A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-09-29 | 1990-03-31 | 1990-09-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-09-29 | 1994-03-31 | 1994-09-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-09-29 | 1998-03-31 | 1998-09-30 | $7700.00 | Window Closed / Lapsed |